GAMCO Investors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.7M Sell
93,220
-19,493
-17% -$1.5M 0.07% 308
2025
Q4
$8.94M Sell
112,713
-14,768
-12% -$1.16M 0.09% 253
2025
Q3
$9.61M Sell
127,481
-4,300
-3% -$295K 0.09% 235
2025
Q2
$9.09M Sell
131,781
-3,215
-2% -$211K 0.09% 239
2025
Q1
$9.15M Sell
134,996
-8,857
-6% -$530K 0.1% 225
2024
Q4
$6.46M Sell
143,853
-18,694
-12% -$1.05M 0.07% 298
2024
Q3
$10.2M Sell
162,547
-4,665
-3% -$272K 0.1% 226
2024
Q2
$9.88M Sell
167,212
-19,302
-10% -$1.21M 0.11% 226
2024
Q1
$14.9M Sell
186,514
-21,390
-10% -$1.63M 0.15% 171
2023
Q4
$16.4M Sell
207,904
-7,742
-4% -$551K 0.18% 157
2023
Q3
$15.1M Sell
215,646
-2,300
-1% -$163K 0.17% 157
2023
Q2
$15.1M Sell
217,946
-85,216
-28% -$6.06M 0.16% 164
2023
Q1
$22.5M Sell
303,162
-27,592
-8% -$2.31M 0.24% 114
2022
Q4
$30.8M Sell
330,754
-6,596
-2% -$636K 0.33% 90
2022
Q3
$32.2M Sell
337,350
-23,276
-6% -$2.3M 0.38% 69
2022
Q2
$33.4M Buy
360,626
+112,305
+45% +$11M 0.37% 78
2022
Q1
$25.1M Sell
248,321
-5,462
-2% -$574K 0.23% 124
2021
Q4
$26.2M Sell
253,783
-5,778
-2% -$534K 0.22% 126
2021
Q3
$22M Sell
259,561
-7,570
-3% -$634K 0.19% 144
2021
Q2
$22.3M Sell
267,131
-7,675
-3% -$629K 0.19% 149
2021
Q1
$20.7M Sell
274,806
-19,122
-7% -$1.39M 0.18% 153
2020
Q4
$20.1M Sell
293,928
-11,889
-4% -$773K 0.19% 152
2020
Q3
$17.9M Sell
305,817
-21,831
-7% -$1.36M 0.2% 150
2020
Q2
$21.3M Sell
327,648
-154,005
-32% -$9.7M 0.24% 122
2020
Q1
$28.6M Buy
481,653
+51,674
+12% +$3.45M 0.34% 83
2019
Q4
$31.9M Buy
429,979
+740
+0.2% +$52K 0.26% 112
2019
Q3
$27.1M Sell
429,239
-98,694
-19% -$5.85M 0.23% 123
2019
Q2
$28.8M Sell
527,933
-939
-0.2% -$50.6K 0.22% 122
2019
Q1
$28.5M Sell
528,872
-4,141
-0.8% -$256K 0.22% 126
2018
Q4
$34.9M Sell
533,013
-17,304
-3% -$1.29M 0.3% 94
2018
Q3
$43.3M Sell
550,317
-59,723
-10% -$4.27M 0.29% 96
2018
Q2
$39.3M Sell
610,040
-47,430
-7% -$3.13M 0.27% 104
2018
Q1
$40.9M Sell
657,470
-107,776
-14% -$7.73M 0.28% 101
2017
Q4
$55.5M Sell
765,246
-283,990
-27% -$20.6M 0.35% 85
2017
Q3
$85.3M Sell
1,049,236
-31,286
-3% -$2.47M 0.53% 58
2017
Q2
$86.9M Sell
1,080,522
-12,265
-1% -$968K 0.56% 52
2017
Q1
$85.8M Buy
1,092,787
+21,170
+2% +$1.69M 0.54% 55
2016
Q4
$84.6M Buy
1,071,617
+6,160
+0.6% +$498K 0.53% 57
2016
Q3
$94.8M Sell
1,065,457
-74,521
-7% -$7.03M 0.62% 44
2016
Q2
$109M Sell
1,139,978
-48,922
-4% -$4.88M 0.72% 33
2016
Q1
$123M Buy
1,188,900
+10,112
+0.9% +$983K 0.81% 28
2015
Q4
$115M Sell
1,178,788
-36,805
-3% -$3.6M 0.75% 33
2015
Q3
$117M Sell
1,215,593
-144,385
-11% -$15.2M 0.77% 30
2015
Q2
$143M Sell
1,359,978
-78,185
-5% -$7.99M 0.77% 29
2015
Q1
$148M Sell
1,438,163
-51,100
-3% -$5.17M 0.78% 31
2014
Q4
$143M Sell
1,489,263
-38,747
-3% -$3.41M 0.75% 30
2014
Q3
$122M Sell
1,528,010
-35,632
-2% -$2.81M 0.65% 34
2014
Q2
$118M Sell
1,563,642
-5,039
-0.3% -$381K 0.62% 40
2014
Q1
$117M Sell
1,568,681
-31,656
-2% -$2.24M 0.63% 37
2013
Q4
$115M Sell
1,600,337
-3,205
-0.2% -$206K 0.61% 43
2013
Q3
$91M Sell
1,603,542
-1,965
-0.1% -$117K 0.53% 50
2013
Q2
$91.8M Buy
+1,605,507
New +$93M 0.58% 47

Other funds holding CVS

GAMCO Investors's CVS Position: Q1 2026 in Review

GAMCO Investors reduced its CVS Health (CVS) stake by 17% in Q1 2026, selling an estimated $1.5M and leaving 93,220 shares worth $6.7M. The position accounts for 0.07% of the portfolio, ranked #308.

GAMCO Investors first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $148M in Q1 2015. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • GAMCO Investors held 93,220 shares of CVS Health worth $6.7M as of Q1 2026.
  • GAMCO Investors sold 19,493 CVS Health shares in Q1 2026, an estimated $1.5M.
  • CVS Health made up 0.07% of GAMCO Investors's portfolio in Q1 2026, its #308 holding.
  • GAMCO Investors first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • GAMCO Investors's CVS Health position peaked at $148M in Q1 2015.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on GAMCO Investors's 13F filing for Q1 2026, filed 14 May 2026.